Breckenridge Launches Generic Cymbalta
Cymbalta is currently approved for the treatment of generalized anxiety disorder, fibromyalgia, major depressive disorder, chronic musculoskeletal pain (eg, low back pain, osteoarthritis pain), and diabetic peripheral neuropathic pain. Although the exact mechanisms of Cymbalta are unknown, they are believed to be related to the potentiation of serotonergic and noradrenergic activity in the CNS.
Duloxetine Delayed-Release Capsules are available in 20mg, 30mg, and 60mg strengths.
For more information call (561) 443-3314 or visit Bpirx.com.